Al Hammadi Holding Company Stock

Equities

4007

SA13J051UJH4

Healthcare Facilities & Services

End-of-day quote Saudi Arabian S.E. 06:00:00 2024-04-23 pm EDT 5-day change 1st Jan Change
57.7 SAR -0.17% Intraday chart for Al Hammadi Holding Company -2.20% -2.86%
Sales 2024 * 1.29B 344M Sales 2025 * 1.43B 382M Capitalization 9.23B 2.46B
Net income 2024 * 316M 84.3M Net income 2025 * 369M 98.44M EV / Sales 2024 * 7.33 x
Net Debt 2024 * 220M 58.69M Net Debt 2025 * 447M 119M EV / Sales 2025 * 6.76 x
P/E ratio 2024 *
28.7 x
P/E ratio 2025 *
25 x
Employees -
Yield 2024 *
2.37%
Yield 2025 *
2.77%
Free-Float 75.96%
More Fundamentals * Assessed data
Dynamic Chart
Al Hammadi Sells Land Property in Riyadh for SAR125 Million MT
Al Hammadi Holding Announces Distribute Cash Dividends for the Fourth Quarter of 2023, Payable on April 04, 2024 CI
Al Hammadi Holding Company Reports Earnings Results for the Fourth Quarter Ended December 31, 2023 CI
Al Hammadi Holding Company Reports Earnings Results for the Full Year Ended December 31, 2023 CI
South Korea and UAE Engage in Talks Over Railway, Infrastructure Collaboration MT
Sudair Pharmaceuticals Company announced that it expects to receive SAR 173 million in funding from Al Hammadi Holding Company CI
UAE ENEC signs uranium fuel supply contract with Kazakhstan's National Atomic Company - WAM RE
COP28: UAE signs deal with Bill Gates' nuclear company on advanced reactors RE
Leonardo, first SAF-fueled helicopter flight in the Emirates AN
Al Hammadi Holding Company Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
Al Hammadi Holding Company Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023 CI
Al Hammadi Holding Company Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
Al Hammadi Holding Company Reports Earnings Results for the Full Year Ended December 31, 2022 CI
Al Hammadi Holding Company Declares Distribution of Cash Dividend for Fourth Quarter 2022, Distribution Date Is December 19, 2022 CI
Al Hammadi Holding Company Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022 CI
More news
1 day-0.17%
1 week-2.20%
Current month-0.52%
1 month-9.98%
3 months-8.85%
6 months+15.98%
Current year-2.86%
More quotes
1 week
55.80
Extreme 55.8
60.50
1 month
55.80
Extreme 55.8
64.80
Current year
55.80
Extreme 55.8
71.80
1 year
47.95
Extreme 47.95
71.80
3 years
24.68
Extreme 24.675
71.80
5 years
12.50
Extreme 12.495
71.80
10 years
12.50
Extreme 12.495
71.80
More quotes
Managers TitleAgeSince
Chief Executive Officer 53 96-01-23
Director of Finance/CFO - 18-06-27
Chief Operating Officer 48 08-10-31
Members of the board TitleAgeSince
Chief Executive Officer 53 96-01-23
Chief Operating Officer 48 08-10-31
Chairman 82 16-06-21
More insiders
Date Price Change Volume
24-04-24 57.7 -0.17% 753,768
24-04-23 57.8 -3.99% 675,347
24-04-22 60.2 +0.84% 357,841
24-04-21 59.7 +0.67% 157,954
24-04-18 59.3 +0.51% 427,622

End-of-day quote Saudi Arabian S.E., April 23, 2024

More quotes
Al Hammadi Holding Company, formerly Al Hammadi Company for Development and Investment SJSC, is engaged in management and operation of hospitals and medical centers. The Company’s activities include wholesale and retail trading of medical equipment, pharmaceutical and cosmetic products, establishing, maintaining, managing and operating hospitals and medical centers, wholesale and retail trading of food and beverages, acquisition and rental of land for constructing buildings and investing them by means of selling or renting in favor of the Group, establishment or participation in different industrial projects, establishment of commercial centers, operating, and maintaining them in Saudi Arabia, among others. The Company operates approximately three hospitals. The Company’s subsidiaries include Medical Support Services Company Limited, Pharmaceutical Services Company Limited, Al-Hammadi for Hospitals Operations and Management Company Limited, and Medical Industries Company Limited.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
9
Last Close Price
57.7 SAR
Average target price
60.24 SAR
Spread / Average Target
+4.41%
Consensus